Skip to content
  • Clinical Studies
  • Pharma SOP’s
  • Pharma tips
  • Pharma Books
  • Stability Studies
  • Schedule M

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • GMP Failures & Pharma Compliance
    • Common GMP Failures
    • GMP Documentation & Records Failures
    • Cleaning & Sanitation Failures in GMP Audits
    • HVAC, Environmental Monitoring & Cross-Contamination Risks
  • Toggle search form

Audit Findings on Mismanaged Printed Packaging Material Storage

Posted on November 25, 2025November 25, 2025 By digi


Audit Findings on Mismanaged Printed Packaging Material Storage

Comprehensive Step-by-Step Guide to GMP Storage of Printed Packaging Materials: Preventing Audit Findings and Ensuring Compliance

The pharmaceutical industry demands stringent control over every aspect of drug product manufacturing, including raw materials, components, and packaging materials. One commonly encountered area of regulatory scrutiny involves the gmp storage of printed packaging materials. Improper storage can lead to issues such as mislabelling, use of wrong cartons, and ultimately, significant audit findings from regulatory inspections. This guide provides a structured, stepwise approach to establishing effective control and storage systems for printed packaging materials, ensuring compliance with GMP requirements across US, UK, and EU regulatory frameworks.

Step 1: Understand the Regulatory Requirements for Printed Packaging Material Storage

Before implementing practical controls, it is essential to understand the regulatory foundation. Printed packaging materials (labels, cartons, leaflets) are classified as critical components as their errors can lead to mis-identification of drug products.

  • FDA 21 CFR Part 211 mandates controls over packaging materials to prevent mix-ups and labeling errors.
  • The EU GMP Volume 4, Annex 15 and Annex 1 provide guidelines emphasizing integrity and traceability of packaging materials and components.
  • PIC/S PE 009 advocates robust storage systems including environmental conditions, segregation, and clear labeling.
  • ICH Q7 and WHO GMP guidelines underline the importance of proper storage and documented control of packaging materials.

Key regulatory expectations include:

  • Dedicated storage locations to prevent mix-ups.
  • Segregation of different printed materials and batches.
  • Controlled access to materials storage areas.
  • Environmental conditions monitored and appropriate for material stability.
  • Documented procedures covering receipt, storage, issuance, and handling.

Auditors pay particular attention to these elements to determine compliance and prevent audit findings related to mislabelling or use of wrong cartons.

Step 2: Design and Implement Segregated Storage Systems for Printed Materials

Step two focuses on the physical organization and control of packaging materials within the warehouse. Poor storage practices commonly lead to the accidental use of incorrect printed materials, potentially causing product recalls and regulatory penalties.

Key steps in designing an effective storage system include:

  • Segregation by Material Type and Batch: Each type of printed packaging material (labels, cartons, leaflets) must be stored in dedicated shelving or bins, clearly marked and separated from other types to prevent mix-ups.
  • Segregation by Batch Number: Each batch of printed materials received should be stored separately, preferably on different shelves or within partitioned compartments.
  • Controlled Access Zones: Storage areas should have controlled entry, allowing only qualified personnel with training in GMP storage of printed packaging materials.
  • Use of Visual Aids and Signage: Use large, clear signs indicating material type, batch codes, and intended use, reducing chances of human error. Color coding can be applied but must be documented in SOPs.
  • Placement of Quarantine and Rejected Materials: Materials pending release or identified as non-conforming must have distinct quarantine areas that are physically separated and labeled to prevent accidental use.
  • Environmental Controls: Storage conditions such as temperature, humidity, and lighting must comply with specifications ensuring print quality and material integrity. Continuous monitoring and alarm systems should be implemented when required.
Also Read:  Blending Equipment Selection and Controls Under GMP

Implementing these organizational principles reduces audit findings related to wrong cartons or mislabelling through accidental material interchange. Regular reevaluation of storage layout during annual facility audits helps maintain compliance and optimize flow.

Step 3: Establish Robust Procedures for Receipt, Identification and Record Keeping

The third step involves creating and enforcing procedures to ensure every batch of printed packaging materials is correctly identified upon receipt and throughout storage. This phase is critical to maintain traceability and prevent mix-ups.

  • Receipt and Inspection: Upon delivery, printed materials must be inspected against documentation (purchase order, certificate of analysis) for correctness and integrity before acceptance into inventory.
  • Unique Identification: Assign each received batch a unique identifier or barcode to track storage location and inventory movements.
  • Labeling of Storage Containers: All stored materials must carry labels with key information including material type, batch number, quantities, supplier, and status (quarantined, released, rejected).
  • Inventory Management Systems: Use electronic or paper-based inventory systems to record receipt, storage location, quantity, and issuance history. The system must have controls to prevent unauthorized transactions.
  • Periodical Inventory Counts and Reconciliation: Conduct regular physical inventory checks reconciled against records to identify discrepancies early. This step mitigates risks of losing track of materials or accidental reuse of expired batches.
  • Documentation Control: Follow SOPs to ensure all receiving, inspection, storage, issuance, and disposition activities are documented accurately and retained per regulatory timelines.
Also Read:  SOP for Control and Storage of Printed Packaging Materials

Well-documented controls create audit trails that support compliance and reduce audit findings related to mislabelling or issuance errors of printed packaging materials.

Step 4: Implement Controlled Issuance and Handling Procedures

Effective issuance and handling of packaging materials are pivotal in preventing mix-ups during manufacturing. This step extends control beyond storage into the material withdrawal phase.

  • Authorization Controls: Only authorized personnel should be permitted to withdraw printed packaging materials, after verification against approved production orders.
  • Use of Pick Lists and Material Reservations: Issuance should be driven by formal pick lists generated from production schedules, ensuring only correct materials are issued.
  • Verification and Double Checks: Prior to issuance, verification steps such as batch number checks, label reconciliation, and potentially independent double checks should be performed to confirm correctness.
  • Temporary Holding Areas: Once issued, materials should be placed in designated holding areas near production lines, segregated and clearly identified to avoid mix-ups before use.
  • Handling Precautions: Materials must be handled carefully to avoid damage, contamination, or mixing. SOPs should specify handling steps with GMP compliance in mind.
  • Return of Unused Materials: Clear procedures should be in place for the return and quarantine of unused or partially used materials, including re-inspection and re-labeling if necessary.

Implementing these procedures ensures that manufacturing receives the correct packaging materials, minimizing risks associated with wrong cartons, which are common audit findings during FDA or MHRA inspections.

Step 5: Conduct Regular Training and Continuous Improvement Activities

Training and continuous improvement sustain a quality culture and compliance over time. Storage and control of printed packaging materials require constant vigilance by warehouse, QA, and manufacturing personnel.

  • Initial and Refresher Training: All personnel involved in storage and handling of printed packaging materials must receive GMP-focused training emphasizing the importance of proper segregation, identification, and handling.
  • Audit Preparedness: Train staff on audit expectations related to printed packaging materials, common pitfalls, and how to maintain documentation integrity and cleanliness of storage areas.
  • Incident Investigation and CAPA: Any instances of mislabelling, discovery of wrong cartons, or material mix-ups must be documented, investigated promptly, and addressed with corrective and preventive actions.
  • Periodic Internal Audits: Conduct self-inspections of GMP storage of printed packaging materials to proactively identify risks and implement improvements before regulatory audits.
  • Feedback Integration: Encourage frontline personnel to report challenges and improvement ideas, fostering a proactive approach to quality management.
  • Management Review and Metrics: Track key performance indicators such as storage discrepancies, audit findings, and training effectiveness to drive continuous compliance improvement.
Also Read:  GMP Storage of Printed Packaging Materials: Controls and Risks

Emphasizing ongoing education and quality culture minimizes the likelihood of recurrence of common packaging material errors noted during inspections under EMA, FDA, or PIC/S GMP guidelines.

Step 6: Monitor Environmental Conditions and Material Integrity

Integrity of printed packaging materials can be compromised by inappropriate environmental conditions. This final step addresses the controlled environment and stability considerations critical to GMP storage of printed packaging materials.

  • Environmental Monitoring: Monitor temperature, humidity, and light exposure within packaging materials storage areas using validated instruments with alarms for excursions.
  • Storage Specifications: Ensure printed materials are stored per manufacturer or internal specifications—some materials may require temperature control or humidity limits to preserve adhesive quality or print legibility.
  • Pest Control and Cleanliness: Regular pest inspections and cleaning schedules prevent contamination risks to printed packaging materials.
  • Material Shelf Life and Expiry Management: Maintain clear records of expiration dates; implement “First Expiry First Out” (FEFO) or similar inventory rotation principles.
  • Handling Damaged or Deteriorated Materials: Procedures must define actions for damaged cartons or labels, including isolation and disposition to avoid use in production.
  • Validation of Storage Conditions: Environment and storage systems should be qualified and validated, with documentation to support material integrity over time.

By controlling environmental and material integrity aspects systematically, the risk of quality defects and subsequent regulatory audit findings can be substantially reduced.

Conclusion: Ensuring Compliance Through Meticulous Control of Printed Packaging Materials Storage

Regulatory agencies including FDA, MHRA, and EMA consistently highlight deficiencies in printed packaging material storage as critical GMP audit findings affecting drug product quality and patient safety. By following this step-by-step guide, pharmaceutical manufacturers can establish robust systems that address the root causes of mislabelling, wrong cartons, and other packaging-related errors.

Implementing validated, well-documented procedures; designing segregated and controlled storage facilities; enforcing strict receipt, issuance, and handling controls; monitoring environmental conditions; and fostering continuous personnel training collectively form the foundation of a compliant storage strategy. For further reference, consult the detailed regulatory requirements under FDA packaging regulations and the PIC/S GMP guidelines.

Pharmaceutical QA, QC, manufacturing, and supply chain professionals are encouraged to align their internal processes with these globally recognized GMP principles. Doing so reduces the likelihood of costly regulatory audit observations and enhances overall product integrity and patient safety.

Printed Materials Tags:audit, mislabelling, pharmagmp, printed materials

Post navigation

Previous Post: Quarantine and Release Procedure for Intermediates in Warehouses
Next Post: Inventory and Reconciliation of Printed Components to Prevent Mix Ups

Quick Guide

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • International GMP Inspection Standards and Harmonization
    • Global GMP Inspection Frameworks
    • WHO Prequalification and Inspection Systems
    • US FDA GMP Inspection Programs
    • EMA and EU GMP Inspection Practices
    • PIC/S Role in Harmonized Inspections
    • Country-Specific Inspection Standards (e.g., UK MHRA, US FDA, TGA)
  • GMP Blog

Latest Posts

  • GMP-cGMP Regulations & Global Standards
    • FDA cGMP Regulations for Drugs & Biologics
    • cGMP Requirements for Pharmaceutical Manufacturers
    • ICH Q7 and API GMP Expectations
    • Global & ISO-Based GMP Standards
    • GMP for Medical Devices & Combination Products
    • GMP for Pharmacies & Hospital Pharmacy Settings
  • Applied GMP in Pharma Manufacturing & Operations
    • GMP for Pharmaceutical Drug Product Manufacturing
    • GMP for Biotech & Biologics Manufacturing
    • GMP Documentation
    • GMP Compliance
    • GMP for APIs & Bulk Drugs
    • GMP Training
  • Computer System Validation (CSV) & GxP Computerized Systems
    • CSV Fundamentals in Pharma & Biotech
    • FDA CSV Guidance & 21 CFR Part 11 Alignment
    • GAMP 5 & Risk-Based Validation Approaches
    • CSV in Pharmaceutical & GxP Industries (Use-Cases & System Types)
    • CSV Documentation
    • CSV for Regulated Equipment & Embedded Systems
  • Data Integrity & 21 CFR Part 11 Compliance
    • Data Integrity Principles in cGMP Environments
    • FDA Data Integrity Guidance & Expectations
    • 21 CFR Part 11 – Electronic Records & Signatures
    • Data Integrity in GxP Computerized Systems
    • Data Integrity Audits
  • Pharma GMP & Good Manufacturing Practice
    • FDA 483, Warning Letters & GMP Inspections
    • Data Integrity, ALCOA+ & Part 11 / Annex 11
    • Process Validation, CPV & Cleaning Validation
    • Contamination Control & Annex 1
    • PQS / QMS / Deviations / CAPA / OOS–OOT
    • Documentation, Batch Records & GDP
    • Sterility, Microbiology & Utilities
    • CSV, GAMP 5 & Automation
    • Dosage-Form–Specific GMP (Solids, Liquids, Sterile, Topicals)
    • Supply Chain, Warehousing, Cold Chain & GDP
Widget Image
  • Never Assign Batch Release Responsibilities to Non-QA Personnel in GMP

    Never Assign Batch Release Responsibilities… Read more

  • Manufacturing & Batch Control
    • GMP manufacturing process control
    • Batch Manufacturing record requirements
    • Master Batch record template for pharmaceuticals
    • In Process control checks in tablet manufacturing
    • Line clearance procedure before batch start
    • Batch reconciliation in pharmaceutical manufacturing
    • Yield reconciliation GMP guidelines
    • Segregation of different strength products GMP
    • GMP controls for high potency products
    • Cross Contamination prevention in manufacturing
    • Line clearance checklist for production
    • Batch documentation review before qa release
    • Process parameters control limits in pharma
    • Equipment changeover procedure GMP
    • Batch manufacturing deviation handling
    • GMP expectations for batch release
    • In Process sampling plan for tablets
    • Visual inspection of dosage forms GMP requirements
    • In Process checks for filled vials
    • Startup and Shutdown procedure for manufacturing line
    • GMP requirements for blending and mixing operations
    • Process Control strategy in pharmaceutical manufacturing
    • Uniformity of dosage units in process controls
    • GMP checklist for oral solid dosage manufacturing
    • Process Control
    • Batch Documentation
    • Master Batch Records
    • In-Process Controls
    • Line Clearance
    • Yield & Reconciliation
    • Segregation & Mix-Ups
    • High Potency Products
    • Cross Contamination Control
    • Line Clearance
    • Batch Review
    • Process Parameters
    • Equipment Changeover
    • Deviations
    • Batch Release
    • In-Process Sampling
    • Visual Inspection
    • In-Process Checks for Vials
    • Start-Up & Shutdown
    • Blending & Mixing
    • Control Strategy
    • Dosage Uniformity
    • Hold Time Studies
    • OSD GMP Checklist
  • Cleaning & Contamination Control
  • Warehouse & Material Handling
    • Warehouse GMP
    • Material Receipt
    • Sampling
    • Status Labelling
    • Storage Conditions
    • Rejected & Returned
    • Reconciliation
    • Controlled Drugs
    • Dispensing
    • FIFO & FEFO
    • Cold Chain
    • Segregation
    • Pest Control
    • Env Monitoring
    • Palletization
    • Damaged Containers
    • Stock Verification
    • Sampling & Weighing Areas
    • Issue to Production
    • Traceability
    • Printed Materials
    • Intermediates
    • Cleaning & Housekeeping
    • Status Tags
    • Warehouse Audit
  • QC Laboratory & Testing
    • Analytical Method Validation
    • Chromatography Systems
    • Dissolution Testing
    • Assay & CU
    • Impurity Profiling
    • Stability & QC
    • OOS Investigations
    • OOT Trending
    • Sample Management
    • Reference Standards
    • Equipment Calibration
    • Instrument Qualification
    • LIMS & Electronic Data
    • Data Integrity
    • Microbiology QC
    • Sterility & Endotoxin
    • Environmental Monitoring
    • QC Documentation
    • Results Review
    • Method Transfer
    • Forced Degradation
    • Compendial Methods
    • Cleaning Verification
    • QC Deviations & CAPA
    • QC Lab Audits
  • Manufacturing & In-Process Control
    • Batch Manufacturing Records
    • Batch Manufacturing Records
    • Line Clearance
    • In-Process Sampling & Testing
    • Yield & Reconciliation
    • Granulation Controls
    • Blending & Mixing
    • Tablet Compression Controls
    • Capsule Filling Controls
    • Coating Process Controls
    • Sterile & Aseptic Processing
    • Filtration & Sterile Filtration
    • Visual Inspection of Parenteral
    • Packaging & Labelling Controls
    • Rework & Reprocessing
    • Hold Time for Bulk & Intermediates
    • Manufacturing Deviations & CAPA
  • Documentation, Training & QMS
    • SOP & Documentation Control
    • Training & Competency Management
    • Change Control & QMS Lifecycle
    • Internal Audits & Self-Inspection
    • Quality Metrics, Risk & Management Review
  • Production SOPs
  • QC Laboratory SOPs
    • Sample Management
    • Analytical Methods
    • HPLC & Chromatography
    • OOS & OOT
    • Data Integrity
    • Documentation
    • Equipment
  • Warehouse & Materials SOPs
    • Material Receipt
    • Sampling
    • Storage
    • Dispensing
    • Rejected & Returned
    • Cold Chain
    • Stock Control
    • Printed Materials
    • Pest & Housekeeping
  • Cleaning & Sanitization SOPs
  • Equipment & Qualification SOPs
  • Documentation & Data Integrity SOPs
  • Deviation/OOS/CAPA SOPs
    • Deviation Management
    • Root Cause
    • CAPA
    • OOS/OOT
    • Complaints
    • Recall
  • Training & Competency SOPs
    • Training System
    • Role-Based Training
    • OJT
    • Refresher Training
    • Competency
  • QA & QMS Governance SOPs
    • Quality Manual
    • Management Review
    • Internal Audit
    • Risk Management
    • Vendors & Outsourcing
  • About Us
  • Privacy Policy & Disclaimer
  • Contact Us

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme